Navigation Links
Leica Biosystems Receives FDA Approval for the Fully Automated Bond Oracle™ HER2 IHC System on the Leica BOND-MAX
Date:4/25/2012

NEWCASTLE UPON TYNE, England, April 25, 2012 /PRNewswire/ --

Leica Biosystems, a division of Leica Microsystems, announced that it has received Pre-Market Approval from the U.S. Food and Drug Administration for the Leica Bond Oracle HER2 IHC System (Product Code TA9147) with the Leica BOND-MAX, establishing their commitment to developing quality companion diagnostic products. The Leica Bond Oracle HER2 IHC System is a complete solution of ready-to-use reagents, HER2 control slides and Leica BOND-MAX instrumentation, designed to deliver increased diagnostic confidence and drive laboratory efficiency in HER2 IHC testing.

"The Leica Bond Oracle HER2 IHC System demonstrates high concordance to HER2 FISH," comments Arnd Kaldowski, President of Leica Biosystems. "The Leica Bond Oracle HER2 IHC System is validated as a fully-automated HER2 IHC test, and delivers the diagnostic confidence that comes with proven HER2 FISH concordance. With the Oracle system, laboratories also obtain the speed and efficiencies of Leica BOND-MAX instrumentation, delivering more effective workflow management."

The Leica Bond Oracle HER2 IHC System is intended for use on formalin-fixed, paraffin-embedded tissue, and can be used simultaneously with all other BOND protocols allowing unparalleled flexibility and workflow efficiency.

In clinical trials the Leica Bond Oracle HER2 IHC System achieved 2x2 concordance of 87.6% and a positive agreement of 93.8% with the Abbott Molecular PathVysion HER2 DNA Probe kit, considered the gold standard for assessment of HER2 status.

Full automation of HER2 IHC testing facilitates decreased process variation, increased protocol standardization and the delivery of consistent results. Confidence is further enhanced by the use of HER2 Control Slides demonstrating 0, 1+, 2+ and 3+ staining. "Use of the 2+ (equivocal) cell line, has the potential to improve assay performance, as this is a sensitive indicator of problems associated with antigen retrieval, primary antibody, or detection system," says Dr. Anthony O'Grady, Beaumont Hospital, Ireland.

Leica Bond Oracle HER2 IHC System is a semi-quantitative immunohistochemical (IHC) assay to determine HER2 (Human Epidermal Growth Factor Receptor 2) oncoprotein status in breast cancer tissue processed for histological evaluation. The Leica Bond Oracle HER2 IHC System is indicated as an aid in the assessment of patients for whom Herceptin® (trastuzumab) treatment is being considered.

Leica Microsystems is a world leader in microscopes and scientific instruments. Founded as a family business in the nineteenth century, the company's history was marked by unparalleled innovation on its way to becoming a global enterprise. Its historically close cooperation with the scientific community is the key to Leica Microsystems' tradition of innovation, which draws on users' ideas and creates solutions tailored to their requirements. At the global level, Leica Microsystems is organized in four divisions, all of which are among the leaders in their respective fields: the Life Science Division, Industry Division, Biosystems Division and Medical Division.

Leica Microsystems' Biosystems Division, also known as Leica Biosystems, offers histopathology laboratories the most extensive product range with appropriate products for each work step in histology and for a high level of productivity in the working processes of the entire laboratory. The company is represented in over 100 countries with 12 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers. The company is headquartered in Wetzlar, Germany.

For more information contact:

Dean Hutchinson
Marketing Communications Manager
Leica Biosystems Ltd
Balliol Business Park West
Benton Lane
Newcastle upon Tyne
NE12 8EW
Telephone: +44-191-215-0567
Fax: +44-191-215-1152
Direct Line: +44-191-215-4205
Email: dean.hutchinson@leica-microsystems.com


'/>"/>
SOURCE Leica Microsystems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Medical Technologies and Leica Microsystems Announce Collaboration
2. Evergreen Eye Center Introduces Groundbreaking Leica M22 Surgical Microscope for Cataract Surgery to the US
3. Incept BioSystems Initiates First Human Clinical Trial of its SMART Embryo Culture System for In Vitro Fertilization (IVF)
4. NEXUS Biosystems Acquires Tecan Groups REMP Sample Management Business
5. NEXUS Biosystems Completes Acquisition of REMP Sample Management Business From Tecan Group
6. Biosystems International Merges With Microbiochips
7. Incept BioSystems Completes First Human Clinical Trial of the SMART Start™ Embryo Culture System and Submits 510(k) Application to the FDA
8. Berg Biosystems and GNS Healthcare Announce Joint Venture - MAP Biosystems
9. Pancreas-targeted siRNA In Vivo Transfection Kit from Altogen Biosystems
10. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
11. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... FLINT, Mich. , April 28, 2016 /PRNewswire/ ... transaction . Diplomat Pharmacy, Inc. (NYSE: DPLO), the ... it has signed a definitive agreement to acquire ... Advanced Specialty Pharmacy ("TNH"), a leading specialty pharmacy ... Van Nuys, California . In 2015, ...
(Date:4/28/2016)... , April 28, 2016  Marking its one ... breast and ovarian cancer risk test, Color ... 30 genes that highly impact the most common ... today, the Color Test analyzes hereditary cancer risks ... and uterine cancers. The Color Test is physician ...
(Date:4/28/2016)... 28, 2016 Treato , ... healthcare, announced today that it has been named a ... Vendor in Life Sciences, 2016, Stephen Davies ... report focuses on life-science- oriented analytics, algorithms and smart ... and doctors, confirm medication ingestion, and analyze unstructured information. ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... In an article ... shares her enthusiasm for Botox and lip injections, which she underwent in order to ... Coachella Valley Music and Arts Festival. The article explains that Ms. Mirmelli’s situation is ...
(Date:4/29/2016)... ... April 29, 2016 , ... On Tuesday, April 26, ... the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, the “Rural ... (R - Cumming), offers a 70% tax credit to individuals and corporations which donate ...
(Date:4/29/2016)... ... April 29, 2016 , ... Coast Dental Fort Stewart is celebrating ... new location in the Exchange Furniture Mall at 112 Vilseck Road in Fort Stewart. ... Smart TV. Plus attendees will have the opportunity to meet general dentists Thomas Richards, ...
(Date:4/29/2016)... ... April 29, 2016 , ... World Patent ... Gyrociser, an exercise invention which aids in proper muscle development. , "The Gym ... and Creative Director of World Patent Marketing. "Globalization has threatened the future growth ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that ... head and neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to ... AIRWAY™ is a newly patented safety device secured by nasal surgeons onto the ...
Breaking Medicine News(10 mins):